Amphotericin B and itraconazole are the mainstay of treatment [5] , and secondary prophylaxis with itraconazole is effective in reducing relapse rates in patients with AIDS [6] . However, despite appropriate treatment, the in-hospital mortality rate remains approximately 20% [7, 8] .
While the vast majority of penicilliosis were reported in patients with AIDS, a smaller proportion of cases were described in secondary immunodeficiency states, such as renal [9] or hematopoietic stem cell transplants [10] , hematological malignancies, autoimmune diseases, and diabetes mellitus [11] . Penicilliosis in otherwise healthy persons is uncommon. The fact that penicilliosis is an AIDS-defining illness principally occurring in patients with CD4
1 lymphocyte count below 100 cells/ mm 3 [12] suggests that individuals who are HIV negative and without secondary immunodeficiencies may have primary immune defects, especially those with fatal disseminated disease. However, information on the spectrum of primary immunodeficiencies (PIDs) and genetic susceptibility associated with P. marneffei infection is lacking in the literature, and collective data on penicilliosis in HIV-negative children are even scarcer.
In this study, we analyzed the clinical features and immunological evaluations of 5 children with penicilliosis. None had HIV infection, and all had abnormal immune functions at the time of infection. Four patients had recurrent infections suggestive of underlying immunodeficiencies, and 1 was confirmed to have hyperimmunoglobin E (hyper-IgE) syndrome. We proceeded with performing a systematic review of the literature on penicilliosis in children without HIV infection. The objective is to summarize the range of underlying immune defects in this group of patients. Based on the current understanding of immune response to fungal pathogens in humans, we propose an approach to immunological evaluations in patients with penicilliosis.
METHODS

Case Reports
In the past 15 years, 4 patients aged 3-16 years were diagnosed to have P. marneffei infection and were managed in Queen Mary Hospital. In 2009, we received a referral for genetic diagnosis of a 2-year-old girl with disseminated penicilliosis and suspected PID from Guangzhou Children's Hospital. Within the study period, only 1 pediatric AIDS patient under our care had a past history of disseminated penicilliosis, which had been treated in another hospital.
All patients had culture-proven P. marneffei infection and underwent detailed immunological evaluations. Using a candidate gene approach, polymerase chain reaction (PCR)-direct sequencing was performed on the genes STAT3, CARD9, IL12B, IL12RB1, IFNGR1, and AIRE in 4 patients based on the clinical features and immunological evaluations. Full clinical details of the patients and methodology of PCR-direct sequencing are provided as supplementary information. Consent for genetic diagnosis was obtained from parents, and the study was approved by The Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. [13] . Diagnosis is confirmed by positive culture of P. marneffei from blood or other affected sites, or demonstrated by direct microscopy or histopathology in an individual with an illness consistent with endemic mycoses. P. marneffei demonstrates characteristic thermal dimorphism and microscopic morphology, and can also be diagnosed by serology or molecular techniques such as PCR [14] .
Systematic Review
Search Strategy
Inclusion and Exclusion Criteria
Original studies reporting patients ,16 years of age with penicilliosis as defined above were included for analysis. They were further classified into 3 groups: patients with confirmed primary or secondary immunodeficiencies, patients with documented negative HIV status and without definitive diagnosis of immunodeficiency, and patients whose HIV and immune status was not specified.
The following exclusion criteria were applied: (1) articles on mycology, diagnostics, antifungal susceptibility and experimental animal studies, (2) general review articles on penicilliosis, and (3) case reports or series involving HIV-positive individuals. For duplicate publications, the most recent article was used for data extraction.
Data Extraction
The following data were extracted and tabulated: year of publication, demographics, clinical presentation and outcome of penicilliosis, underlying disease, HIV status, and immunological investigations.
RESULTS
Patient 1
A 15-year-old boy (patient 1 [P1]) presented with fever and left supraclavicular mass for 2 weeks. Computed tomography (CT) scan revealed extensive cervical, mediastinal, and intra-abdominal lymphadenopathy. Fine-needle aspiration of the cervical lymph node for culture yielded P. marneffei. Blood for fungal culture was negative. He was treated with 2 weeks of amphotericin B with good clinical response.
P1 had recurrent oral thrush and paronychia since infancy, but did not have history of skin abscess, pneumonia, or invasive infections. His serum immunoglobin G (IgG) and immunoglobin A (IgA) were elevated, while immunoglobin M (IgM) and immunoglobin E (IgE) were normal. Nitroblue tetrazolium (NBT) test was normal. Lymphocyte subset showed low CD4 (297/lL) and natural killer (NK) cells (52/lL). HIV serology was negative. Lymphocyte proliferation was mildly impaired. As chronic mucocutaneous candidiasis (CMC) is a manifestation of autoimmune polyglandular syndrome, free T4, TSH, PTH, and cortisol were examined and all were normal. Autoantibody screening was negative. Upon follow-up, P1 still had exacerbations of oral candidiasis and chronic paronychia despite itraconazole prophylaxis. He remained mildly lymphopenic (1.1 3 10 9 /L). CD4 and NK cell counts were persistently low 1 year after recovery from penicilliosis (324/lL and 54/lL, respectively).
Patient 2
Patient 2 (P2) was a 7-year-old girl with longstanding history of recurrent oral candidiasis and sinopulmonary infections since infancy. She presented with fever and cough for 3 weeks. Physical findings included finger clubbing, bilateral perforated tympanic membranes with purulent discharge, coarse crepitations in the left chest, and hepatosplenomegaly. Nasopharyngeal aspirate was positive for pandemic H1N1 influenza A virus. She had persistent fever despite administration of intravenous antibiotics and oseltamivir. Thorax CT scan showed mediastinal and hilar lymphadenopathy with multiple thin-walled pulmonary cystic cavities. Culture from bronchoalveolar lavage yielded P. marneffei and cytomegalovirus, while tuberculosis PCR was negative. Culture from ear swab yielded mixed growth of Candida albicans and C. parapsilosis. She was treated with liposomal amphotericin B for 6 weeks and ganciclovir for 4 weeks, followed by itraconazole prophylaxis. Immunological investigations showed lymphopenia, especially NK cells. IgG and IgA were elevated, while IgM and IgE were normal. Anti-double-stranded DNA was above 450 IU/mL but she did not have any clinical features of systemic lupus erythematosus or rheumatological disorders. Anti-extractable nuclear antigen and thyroid autoantibodies were negative. Thyroid and parathyroid hormones were normal. Upon follow-up, lymphocyte count returned to normal, but NK cells remained diminished. Mitogen-stimulated lymphocyte proliferation was normal. HIV status was negative.
Patient 3
A 5 year-old girl (patient 3 [P3]) presented with fever and right cervical lymphadenopathy. Lymph node biopsy yielded Mycobacterium tuberculosis and P. marneffei. She was treated with quadruple antituberculosis therapy and itraconazole. Abdomen CT scan showed calcified axillary, mesenteric, and retroperitoneal lymph nodes. Serum IgG was slightly elevated, while IgA and IgM were normal. Lymphocyte subset showed low NK cell count. HIV status was negative. Lymphocyte proliferation and NK microcytotoxicity assay were normal. Phytohemagglutinin (PHA)-stimulated interferon-c-secreting cells measured by enzyme-linked immunospot assay were reduced on 2 occasions, while interleukin 12 (IL12)-secreting cells were comparable to control. However, she had absent production of interferon-c and negligible interleukin 2 to recall antigens, including Candida and Cryptococcus, as well as tuberculin purified protein derivative (PPD) to which she had been exposed. PHA-stimulated IL12 receptor expression was normal.
P3 was known to have CMC since infancy. After the episode of tuberculosis and P. marneffei infections, she suffered from recurrent bacterial pneumonia and CMC despite itraconazole prophylaxis. At 11 years old, she had herpes zoster, causing left facial nerve palsy. She developed invasive aspergillosis and hemophagocytic syndrome at 16 years of age, and died of massive pulmonary hemorrhage.
Patient 4
Patient 4 (P4) presented with a 6-week history of fever and cough at 12 months of age. Chest X-ray showed bilateral consolidative and cystic changes. She had pancytopenia, and ultrasound showed gross hepatosplenomegaly. Blood and bone marrow cultures yielded P. marneffei. Lymphocyte subset showed reduced T and NK cells. She was started on itraconazole with satisfactory response. At 17 months, P4 developed right tension pneumothorax, pulmonary aspergillosis, and coagulasenegative Staphylococcus aureus bacteremia. Serum IgE was elevated (1030 IU/mL). Hyper-IgE syndrome was diagnosed and confirmed by mutation in STAT3.
Patient 5
Patient 5 (P5) suffered from disseminated penicilliosis at 3 years of age. Details of his clinical and immunological features were reported previously [15] . Briefly, his clinical features included prolonged fever, purpuric skin rash, hepatosplenomegaly, and ascites, complicated by superimposed Escherichia coli bacteremia, septic shock, and multiorgan failure. P. marneffei was isolated from bone marrow and ascitic fluid. He was treated with amphotericin B for 3 months and adjuvant subcutaneous interferon-gamma therapy for the initial 2 weeks, followed by fluconazole for 1 year. Lymphocyte subset showed low NK cells, while CD4 count was normal. NBT and Candida killing were impaired during acute infection, but both returned to normal 3 months later. Upon follow-up, he remained well without other infections.
Hematological and Immunological Parameters
Blood parameters and immunological evaluations of the 5 patients are summarized in Table 1 . The 2 younger patients (P4 and P5) below the age of 3 years had the most severe disease with pancytopenia and bone marrow involvement. All patients had mild to moderate degrees of anemia and hepatosplenomegaly. Except P3, all were lymphopenic at the time of infection. In particular, CD4 lymphopenia was prominent in P1, P2, and P4. More strikingly, all patients had low NK cell counts, which appeared to be more depressed in those with severe clinical disease. Interferon-c autoantibody was absent and equivocal in P1 and P2, respectively.
Mutation Studies
The severity of penicilliosis, abnormal immunological studies and history of recurrent infections prompted the search for inherited PID syndromes. P4 was confirmed to have autosomal-dominant hyper-IgE syndrome with heterozygous missense mutation in exon 12 of the STAT3 gene (c.1121A . G, p.D374G). As P1, P2, and P3 had history of CMC, the CARD9 gene was sequenced but no mutation was found. In view of the predisposition to fungal infection associated with hyper-IgE syndrome, STAT3 gene was also studied but no mutation was identified. P3 had concomitant M. tuberculosis infection and impaired interferon-c (IFN-c) production in vitro, inherited defects in the IL12/IFN-c axis were considered. No mutations were found in IL12B, IL12RB1, and IFNGR1 genes, which constitute 90% of the group of Mendelian susceptibility to mycobacterial infections [16] .
Systematic Review
The search process and result are illustrated by a flowchart as shown in Figure 1 . Out of 509 clinical case series and reports, 347 articles described penicilliosis in exclusively HIV-infected patients. Penicilliosis associated with secondary immunodeficiencies was all described in adults. One adult patient with hyperIgE syndrome developed P. marneffei and Stenotrophomonas maltophilia lung abscess at 30 years of age, and died of massive hemoptysis and respiratory failure [17] .
After elimination of duplicative reports, data on 32 patients from 28 original articles are presented in Table 2 [1, . Two patients were Thai, while 30 patients were Chinese, residing in mainland China (n 5 26), Hong Kong (n 5 2), and Taiwan (n 5 2). The age at infection ranged from 3 months to 16 years, and 24 patients (75%) were under 5 years. Twentytwo patients (69%) were male. Fever (90%), anemia (72%), hepatosplenomegaly (72%), lymphadenopathy (53%), and thrombocytopenia (34.4%) were the most common clinical presentations. The occurrence of hepatomegaly and splenomegaly was much higher when compared with an adult cohort with HIV (43.9% and 13.5%, respectively) [3] . Skin lesions occur in 70% of adult HIV patients with penicilliosis [3, 8] , commonly appearing as papules with central umbilication or necrotic lesions, but only 3 patients (9.4%) in this current review had skin involvement [1, 23, 33] . Invasive penicilliosis was documented in 22 patients (69%), and systemic dissemination with multiorgan involvement was demonstrated in autopsy from 2 more patients (6.3%). Outcome was stated in 29 patients, and 16 of them died of penicilliosis (55.2%).
Seven patients were diagnosed to have underlying immunodeficiencies, including severe combined immunodeficiency [18] , hyper-IgM syndrome [25] , common variable immunodeficiency [21] , Kostmann syndrome [22] , CD4 lymphopenia [20] , and hypogammaglobulinemia [19, 24] . One patient had aplastic anemia [23] . The patients with severe combined immunodeficiency (SCID), Kostmann syndrome, and aplastic anemia died of invasive penicilliosis.
For the rest of the patients without a definitive diagnosis of PID, HIV infection was reported to be negative in 7 patients. Five died of invasive penicilliosis, but immunological investigations were only mentioned in a baby boy with concomitant candidemia who was found to have low immunoglobin levels, and autopsy revealed thymic atrophy [29] . A 4 year-old girl who recovered from invasive penicilliosis was found to have low CD4 percentage and normal immunoglobin levels, but details of her past health were not described [26] .
HIV status was not stated in the remaining 17 patients, and information on immune status was available in only 4 patients. An 11-year-old boy with relapsed disease had reduced T-lymphocyte count, which normalized upon recovery [33] . Another 5-year-old boy with relapsed disease had normal immunoglobin levels and lymphocyte subset [40] . Both were complete cured of disease. A female infant who died of disseminated penicilliosis had panhypogammaglobulinemia and neutropenia, but there was no conclusive diagnosis of immunodeficiency [34] . Another 1-year-old boy had disseminated penicilliosis with past history of neonatal sepsis, and autopsy showed thymic atrophy, but information on family history and further immunological investigations were not described [39] .
DISCUSSION
In this study, we demonstrated abnormal immunity in 5 pediatric patients suffering from penicilliosis without HIV infection. Penicilliosis was reported in children with various forms of PID, including SCID, congenital neutropenia, common variable immunodeficiency (CVID), hyper-IgM syndrome, and hyper-IgE syndrome, but also in those who were apparently healthy.
Penicilliosis results in high mortality in young infants. Nearly all cases (10/11) under the age of 2 years in the literature were fatal versus 6/18 of those above 2 years. This might also suggest that these infants could have undiagnosed severe immunodeficiencies yet to be defined. The uncommon occurrence of penicilliosis by itself, and rarity of PID, would explain the scarcity of information on this topic. The current knowledge gaps include epidemiology of penicilliosis in children and their immune status, the categories of PID associated with penicilliosis, longterm outcome, and relapse rates. The route by which our patients acquired P. marneffei infection and whether they represented primary infection or reactivation from latent infection was uncertain. Exposure to bamboo rats, which are natural hosts of P. marneffei, was not confirmed as a risk factor for the disease [45] . All of our patients resided in urban areas and did not report known exposure to rodents, but the onset of infection did cluster around the rainy seasons from March to September. We believe that primary infection was likely in infants and children with major immunodeficiency, as rapid progression and dissemination after the very first encounter of the pathogen can be expected.
Reduction in the number of T-lymphocyte or cellular immunity is probably the most important predisposing factor to P. marneffei infection or reactivation, which principally affects patients with AIDS and those receiving systemic immunosuppression. This is supported by reports of penicilliosis in patients with SCID, CVID, and hyper-IgM syndrome. In addition to candidiasis, P2 and P3 had recurrent infections caused by bacteria and virus as well, suggesting a more global impairment in immunity. In contrast, P1 did not have infections other than candidiasis and penicilliosis, suggestive of a unique susceptibility to fungal infections. P4 has genetically proven STAT3 deficiency and is the second reported case of penicilliosis occurring in hyper-IgE syndrome [17] , supporting the important role of T-helper 17 (Th17)-mediated antifungal immune response. Our approach of genetic testing was based on current understanding of immune response toward fungal infection. Recognition of fungal pathogen-associated molecular patterns such as mannans and b-glucans by pattern recognition receptors like dectin-1, and STAT3-dependent induction of Th17 response through the Syk-CARD9 pathway are central to the initiation of fungal immunity. This is followed by activation of phagocytes and macrophages regulated by T-helper 1 cells via the IL12/IFN-c axis.
Although molecular defect in a specific immune pathway could not be identified in these patients, their longstanding history of recurrent infections since infancy suggested that they might have genetic susceptibility to fungal infections. P3 had concurrent tuberculosis and penicilliosis with absent IFN-c production toward Candida and PPD. She could possibly have intrinsic T-cell defect or deficiency of the IL12/IFN-c axis. Three children from our literature review also had tuberculosis [20, 35, 42] . Similarly, disseminated nontuberculous mycobacterial infection and penicilliosis were reported in 3 HIV-negative adults without specific immunodeficiency disorders [46] . A recent study demonstrated IFN-c autoantibody in 8 HIV-negative adults with penicilliosis and nontuberculous mycobacterial infection, nontyphoidal salmonellosis, or melioidosis [47] . The blocking and neutralizing effect of IFN-c autoantibody may lead to functional IFN-c deficiency. These observations suggest the importance of the IL12/IFN-c axis toward host defense against mycobacteria and fungi.
A challenge to our analysis was the lack of information on HIV status and immunological evaluations in over half of the case reports. However, HIV infection was unlikely in pediatric cases published before the early 1990s, as the HIV epidemic in China began in the late 1980s among foreign visitors or Chinese residents who were infected overseas, then later in intravenous drug users. The first vertical transmission of HIV in China was documented in 1995 [48] .
As penicilliosis is an AIDS-defining illness, we propose that it should be regarded as an indicator disease for PID in children without HIV infection or secondary immunodeficiency, unless proven otherwise. A detailed history on previous infections, autoimmune manifestations, and family history should be taken. We recommend a basic panel of immunological evaluations for all children with penicilliosis, including immunoglobin pattern (IgG, IgA, IgM, and IgE), lymphocyte subset, NBT or dihydrorhodamine tests, and IFN-c autoantibody. These patients should be assessed by immunologists. Abnormal results obtained during acute illness should be repeated upon full recovery. A systematic approach will facilitate clinicians to identify patients who warrant candidate gene studies or functional delineation of the pathways involved in immune recognition, T-cell activation and differentiation, cytokine signaling, and phagocytic killing mechanisms toward P. marneffei. The utilization of next-generation sequencing techniques may lead to discoveries of novel monogenic disorders causing unique susceptibility to fungal infections.
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